Sydney, June 27, 2026, 05:01 AEST
- Atlas Arteria shares changed hands at A$5.08 on Friday, just under IFM’s A$5.10 per share cash bid. Turnover hit 20.23 million, close to double the usual amount. Google
- Diamond Infraco, the IFM bid entity, held 50.99% of Atlas Arteria’s voting power as of June 24. The offer is open until July 7. Sydney’s South West
- The S&P/ASX 200 ended Friday up 0.18% at 8,764.20. Australian Securities Exchange
ASX trading is closed for the weekend. Atlas Arteria ASX:ALX finished Friday trading looking less like a toll road play and more like a short-term cash bet on IFM Global Infrastructure Fund’s offer.
Atlas closed at A$5.08, under the A$5.10 cash offer, leaving a 0.4% spread. The shares traded in a tight A$5.08 to A$5.10 range. Despite the small gap, Atlas dropped as the main index gained.
Atlas holders are watching the gap now as they wait for the board to reply, with a response due before the market opens Monday. IFM has already taken its stake past 50%. The offer automatically rolled to 7 p.m. Sydney time on July 7 after Diamond Infraco hit the voting power trigger.
Atlas said June 24 its independent directors are still reviewing the offer and plan to release another supplementary target statement before the market opens June 29. The board said it is still focused on the interests of all securityholders. Newsfile
Atlas made its push last week, saying it would keep value in the public market by aiming for at least 60 cents per security in distributions and moving into exclusive talks to sell its Warnow Tunnel asset in Germany to Eiffage SA EPA:FGR in a deal worth between 100 million and 115 million euros. The company said the sale could add 11 to 13 cents per security in net value, according to its defence filed this week. The Australian
Atlas Arteria’s stock didn’t match the board’s valuation. An independent expert set a range of A$5.39 to A$6.20 per security, both higher than IFM’s offer. Shares have held near A$5.10 after IFM lifted its bid, calling it best and final unless a counter offer shows up. Reuters said IFM’s A$5.10 pitch was a 17.8% premium to Atlas’ closing price before IFM announced its bid in April. Reuters
Citi NYSE:C analysts led by Suraj Nebhani stuck with their neutral rating and A$5.10 target, matching the bid price. They pointed to positives from Atlas’ higher near-term dividend plan, but flagged risks for future payouts. The team wrote they had “some reservations around the ALX investment case longer term” given the chance of lower dividends ahead and the presence of a big activist on the register. The Australian
Adrian Atkins at Morningstar put out a corporate-action note called “Accept IFM’s Reasonable Offer”. Morningstar’s last fair value was A$4.10, so the A$5.10 offer looks like a clear exit, not a lowball, by their numbers. Morningstar
Liquidity is back in focus this week. Atlas changed hands 20.23 million times on Friday, more than double its stated average volume of 10.02 million. When trades pile up near the bid, holders can usually get out, but the book can turn over quickly with the July 7 deadline coming.
IFM said it won’t pay more than A$5.10 for Atlas securities for at least a year after the offer ends, unless someone else comes in with a rival bid. It also warned it might stop buying on-market before the offer period wraps up, with no guarantee it continues to the end. Company Announcements
Monday’s board statement is the next event traders are watching. After that, the market gets seven ASX sessions before the extended offer deadline.
